299 related articles for article (PubMed ID: 22236840)
1. Will molecular diagnosis of drug-resistant tuberculosis improve patient outcomes?
Jonsson G; Furin J
Int J Tuberc Lung Dis; 2012 Jan; 16(1):4-5. PubMed ID: 22236840
[No Abstract] [Full Text] [Related]
2. The "source" of drug-resistant TB outbreaks.
van Helden PD; Victor T; Warren RM
Science; 2006 Oct; 314(5798):419-20. PubMed ID: 17053131
[No Abstract] [Full Text] [Related]
3. Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories.
Van Deun A; Wright A; Zignol M; Weyer K; Rieder HL
Int J Tuberc Lung Dis; 2011 Jan; 15(1):116-24. PubMed ID: 21276307
[TBL] [Abstract][Full Text] [Related]
4. External quality assurance of drug susceptibility testing in the southern African development community.
Mativandlela SP; Brand J; Matlhola N; Sewpersadh M; Olorunju SA; van der Walt ML
Int J Tuberc Lung Dis; 2013 Mar; 17(3):425. PubMed ID: 23407237
[No Abstract] [Full Text] [Related]
5. A comparison of the Xpert(®) MTB/RIF and GenoType(®) MTBDRplus assays in Georgia.
Bablishvili N; Tukvadze N; Avaliani Z; Blumberg HM; Kempker RR
Int J Tuberc Lung Dis; 2015 Jun; 19(6):676-8. PubMed ID: 25946358
[TBL] [Abstract][Full Text] [Related]
6. Performance of culture and drug susceptibility testing in pulmonary tuberculosis patients in northern China.
Qi W; Harries AD; Hinderaker SG
Int J Tuberc Lung Dis; 2011 Jan; 15(1):137-9. PubMed ID: 21276311
[TBL] [Abstract][Full Text] [Related]
7. Advances in rapid diagnosis of tuberculosis disease and anti-tuberculous drug resistance.
Alcaide F; Coll P
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():34-40. PubMed ID: 21420565
[TBL] [Abstract][Full Text] [Related]
8. Anti-tuberculosis drug resistance in new and previously treated pulmonary tuberculosis cases in Burkina Faso.
Sangaré L; Diandé S; Badoum G; Dingtoumda B; Traoré AS
Int J Tuberc Lung Dis; 2010 Nov; 14(11):1424-9. PubMed ID: 20937182
[TBL] [Abstract][Full Text] [Related]
9. Recurrence after successful treatment among patients with multidrug-resistant tuberculosis.
Lee J; Lim HJ; Cho YJ; Park YS; Lee SM; Yang SC; Yoo CG; Kim YW; Han SK; Yim JJ
Int J Tuberc Lung Dis; 2011 Oct; 15(10):1331-3. PubMed ID: 22283890
[TBL] [Abstract][Full Text] [Related]
10. Integrated detection of multi- and extensively drug-resistant tuberculosis using the nitrate reductase assay.
Ramos E; Fissette K; de Rijk P; Palomino JC; Martin A
Int J Tuberc Lung Dis; 2012 Jan; 16(1):110-3. PubMed ID: 22236855
[TBL] [Abstract][Full Text] [Related]
11. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM;
Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911
[No Abstract] [Full Text] [Related]
12. Implementation of the INNO-LiPA Rif. TB® line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia.
Skenders GK; Holtz TH; Riekstina V; Leimane V
Int J Tuberc Lung Dis; 2011 Nov; 15(11):1546-52, i. PubMed ID: 22008771
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and genotypic analysis of multidrug-resistant tuberculosis in Ethiopia.
Agonafir M; Lemma E; Wolde-Meskel D; Goshu S; Santhanam A; Girmachew F; Demissie D; Getahun M; Gebeyehu M; van Soolingen D
Int J Tuberc Lung Dis; 2010 Oct; 14(10):1259-65. PubMed ID: 20843416
[TBL] [Abstract][Full Text] [Related]
14. Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso.
Sangare L; Diande S; Kouanda S; Dingtoumda BI; Mourfou A; Ouedraogo F; Sawadogo I; Nebie B; Gueye A; Sawadogo LT; Traore AS
Ann Afr Med; 2010; 9(1):15-9. PubMed ID: 20418644
[TBL] [Abstract][Full Text] [Related]
15. Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa.
Cox H; Hughes J; Daniels J; Azevedo V; McDermid C; Poolman M; Boulle A; Goemaere E; van Cutsem G
Int J Tuberc Lung Dis; 2014 Apr; 18(4):441-8. PubMed ID: 24670700
[TBL] [Abstract][Full Text] [Related]
16. Totally drug-resistant and extremely drug-resistant tuberculosis: the same disease?
Migliori GB; Centis R; D'Ambrosio L; Spanevello A; Borroni E; Cirillo DM; Sotgiu G
Clin Infect Dis; 2012 May; 54(9):1379-80. PubMed ID: 22492321
[No Abstract] [Full Text] [Related]
17. Frequency and type of microbiological monitoring of multidrug-resistant tuberculosis treatment.
Kurbatova EV; Gammino VM; Bayona J; Becerra M; Danilovitz M; Falzon D; Gelmanova I; Keshavjee S; Leimane V; Mitnick CD; Quelapio MI; Riekstina V; Taylor A; Viiklepp P; Zignol M; Cegielski JP
Int J Tuberc Lung Dis; 2011 Nov; 15(11):1553-5, i. PubMed ID: 22008772
[TBL] [Abstract][Full Text] [Related]
18. [Results of 30 year follow-ups of pulmonary tuberculosis patients contingent with isolated drug resistant or sensitive strains].
Zhukova MP
Probl Tuberk; 1997; (5):12-5. PubMed ID: 9454239
[TBL] [Abstract][Full Text] [Related]
19. Advanced multifocal tuberculous spondylitis without disk involvement and with multidrug-resistant bacilli.
Neher A; Kopp W; Berna G; Frank J; Kohlhäufl M
Clin Infect Dis; 2007 Oct; 45(8):e109-12. PubMed ID: 17879905
[TBL] [Abstract][Full Text] [Related]
20. [The urgency of developing new technologies to detect drug resistance in Mycobacterium tuberculosis].
Zheng RJ; Hu ZY
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jan; 45(1):6-8. PubMed ID: 21418810
[No Abstract] [Full Text] [Related]
[Next] [New Search]
